APR 10, 2019 12:00 PM PDT

Best Practices for Implementing NGS and Positioning for Future Growth: Perspectives from 2 Labs

Sponsored by: Illumina
Speakers
  • Executive Director of the Advanced Diagnostic Laboratories, Moffitt Cancer Center
    Biography
      Dr. Magliocco has over 25 years experience as a Professor, Researcher, Pathologist, Laboratory Director, Consultant, Tissue Banker, and public speaker. He is Board Certified in Anatomic Pathology and has extensive experience and sub-specialty expertise in Breast, Gyn, and Molecular Pathology. He has held continuous peer reviewed funding in translational research and his laboratory is currently investigating the mechanisms of ovarian cancer metastasis and treatment evasion. He has founded numerous molecular diagnostic laboratories in the USA and Canada, has published over 200 manuscripts in oncology, and holds numerous diagnostic technology patents. He is currently Executive Director of Esoteric Laboratory Services at the Moffitt Cancer, as well as Scientific Director for Moffitt Tissue Core, one of the largest bio banking programs in the world. He also directs the newly formed Moffitt Morsani Advanced Diagnostics Laboratories which is focused on accelerating development of new CLIA laboratory diagnostics. Dr Magliocco also directs fellowship programs in Molecular Diagnostics and Digital Pathology. He has held numerous national and international roles including Chair of Pathology for the Radiation Therapy and Oncology Clinical Trials group, member of the NCI GU steering committee, and member of the Canadian Cancer Clinical Trials Network Steering committee, as well as previous editorial position with the Journal of Surgical Oncology and is frequent reviewer for numerous other Oncology and Pathology Journals.
    • Laboratory Operations Director, Navican Precision Cancer Care
      Biography
        Keith Gligorich, PhD, is the Laboratory Operations Director at NAVICAN Precision Cancer Care, an Intermountain Healthcare Company. NAVICAN provides TheraMap™, an end-to-end solution helping oncologists and patients harness the power of precision genomics, clinical analytics, and patient services for optimal cancer management. Prior to joining NAVICAN, Dr. Gligorich was a Research Assistant Professor in the Department of Pathology at the University of Utah and a Lead Scientist at ARUP Laboratories. In this role, he led a team of scientists focused on developing solid tumor molecular and NGS diagnostic tests. Dr. Gligorich earned a PhD in Chemistry from the University of Utah. He continued his training as a Department of Defense Breast Cancer Research Program Post-Doctoral Fellow at the Huntsman Cancer Institute.

      Abstract

      Personalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and community based cancer medical center – provided their perspectives on how they approach the challenge of addressing this need. The speakers will present on the reasons why they chose to internalize NGS testing, the value it brings to their healthcare system/network and what was involved to actualize their programs. Digital analytics and analysis employed by LTS Health was incorporated to provide feedback on the impact to laboratory operations and forecasting for future growth.  

      Learning Objectives: 

      1. Recognize the biomarkers that prompt the need for a multi-gene panel to maximize testing results from a single tissue biopsy. 
      2. List the attributes of a Comprehensive Genomics Panel that would be used to drive personalized medicine testing using NGS (next-generation sequencing). 
      3. Describe the Molecular Tumor Board considerations when doing case reviews. 
      4. Identify the components of a Quality Management System for NGS (next-generation sequencing) workflows. 


      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      JUN 09, 2021 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      JUN 09, 2021 7:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
      APR 01, 2021 8:00 AM PDT
      C.E. CREDITS
      APR 01, 2021 8:00 AM PDT
      Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
      MAR 16, 2021 10:00 AM PDT
      C.E. CREDITS
      MAR 16, 2021 10:00 AM PDT
      Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
      APR 19, 2021 8:00 AM PDT
      C.E. CREDITS
      APR 19, 2021 8:00 AM PDT
      Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      APR 10, 2019 12:00 PM PDT

      Best Practices for Implementing NGS and Positioning for Future Growth: Perspectives from 2 Labs

      Sponsored by: Illumina

      Specialty

      Molecular Diagnostics

      Pcr/rt-Pcr/real-Time Pcr

      Personalized Medicine

      Molecular Biology

      Dna Sequencing

      Laboratory Testing

      Genomics

      Clinical Diagnostics

      Cell

      Cancer Diagnostics

      Cancer Research

      Research

      Gene Sequencing

      Lab Automation

      Diagnostics

      Geography

      North America63%

      Asia16%

      Europe16%

      Registration Source

      Website Visitors95%

      Job Title

      Scientist21%

      Student14%

      Medical Laboratory Technician14%

      Executive7%

      Facility/Department Manager7%

      Clinical Laboratory Scientist7%

      QC/QA7%

      Research Scientist7%

      Biologist7%

      Marketing/Sales7%

      Organization

      Biotech Company26%

      Clinical Laboratory16%

      Academic Institution16%

      Diagnostic Company11%

      Medical School5%

      Hospital5%

      Non-Profit Organization5%

      Distribution/sales5%

      Government/public5%


      Show Resources
      Loading Comments...
      Show Resources
      Attendees
      • See more